Fritextsökning
Innehållstyper
-
Första genterapin för svår hemofili A godkänd i EU: "Ett medicinsk genombrott"
Den första genterapin för behandling av vuxna med svår hemofili A har fått grönt ljus av EU-kommissionen.
-
Brexit looking back and looking forward
More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards...
-
Acquisition of consulting company Key2Compliance
The Swedish company Key2Compliance, offering services in fields such as pharma and Medtech, has been acquired by German GBA Group.
-
Novavax is developing a vaccine candidate against Covid-19 and seasonal flu
A combined vaccine against both Covid-19 and seasonal flu is showing promising results in studies, according to the American drug developer Novavax. The adjuvan...
-
Anna Törner: ”Orphan Designation – the "petite robe noire" of drug development”
It is easy to cling to various regulatory incentives, like orphan designation, and other expedited pathways, without understanding what they truly mean or wheth...
-
Higher throughput in less time
Do you want to automate your quality processes, shorten inspection times and increase your throughput? Gain inspiration from the experience of the medical techn...
-
Automated dispensing of liquids
Have a look at how you can do easier and faster dispensing on the fly adapted to your needs
-
Ranking: Top 10 highest-paid CEOs in pharma
It's nice to hear that things go well for others, right? Some of those who have done really well – at least financially – are listed here in the ranking of the ...
-
The Swedish National Board of Health and Welfare rejects prioritising andrology as a speciality
Male infertility can be linked to a shorter lifespan and several severe diseases, but when couples who want children are examined, the focus is on the woman. Ex...
-
ZEISS Hosts an exceptional Global Conference on Innovation and Production in Berlin
More than 50 distinguished speakers from leading manufacturing companies.
-
Come see us at the upcoming events!
We have some upcoming events where you can see our latest products live!
-
Study: Popular diabetes treatment is not associated with thyroid cancer
Concerns raised about an association between GLP-1 analogues, used to treat diabetes and obesity, and an increased risk of thyroid cancer are not supported by a...
-
Advanced Microfluidics Flow Analysis Made Easy
Case study with ZEISS Airyscan.
-
Chalmersforskare: Bättre riskbedömning med lipoprotein än kolesterol
I stället för att mäta kolesterolvärdet i blodet för att förutse risken för hjärtinfarkt kan ett enkelt test av lipoproteinmarkörer ge bättre information. Det h...
-
ZEISS presents the "Quality Innovation Days"
The digital event for metrology and software.
-
The Swedish Research Council gets go-ahead for more long-term funding
Following a government decision, the Swedish Research Council will soon be able to approve ten-year grant periods for funding research infrastructure, which may...
-
Quality Assurance for the Highest Medical Standards
Metrology Solutions for Medical Components.
-
Product demo with features, software and best-practices
Get interesting insights about ZEISS O-INSPECT duo in our demo recording.
-
Unexpected study results on testosterone – no reduction in fracture risk
Testosterone treatment is known to increase bone density and bone quality. However, a study now suggests that supplementation with the male sex hormone does not...
-
Don't miss ZEISS Quality Innovation Days
Digital event April 15-19, 2024.
-
Sweden is organising a large life science conference as part of the EU presidency
On 26-27 June, Sweden will host a European meeting on life science.
-
Fuskanklagat pharmabolag lägger ner alzheimerprojekt
Amerikanska Cassava Sciences avbryter utvecklingen av sin läkemedelskandidat inom Alzheimers sjukdom efter misslyckande i en fas III-studie
-
Microscope or Measuring Machine? Both!
Watch our demo recording with features, software and best-practices.
-
BioVentureHub CEO: “Companies with a high degree of interaction achieve greater success”
For the first time since its inception, AstraZeneca’s BioVentureHub can now recruit new companies, as some of its tenants have grown significantly and are leavi...
BREAKING